![Alexandra Dietrich](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alexandra Dietrich
Algemeen Directeur bij Syntacoll Gmbh
Actieve functies van Alexandra Dietrich
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Syntacoll Gmbh
![]() Syntacoll Gmbh Pharmaceuticals: MajorHealth Technology Part of Innocoll Holdings Plc, Syntacoll GmbH is a German pharmaceutical company that develops and manufactures fully resorbable collagen-based implants. The company is based in Saal an der Donau, Germany and was founded in 1992. The CEOs are Alexandra Dietrich and Kimball Hall. Syntacoll is the only development and production site of Innocoll, and their products are manufactured according to GMP and ISO 13485 standards. The company holds a manufacturing license for active substance-containing drugs based on collagen. Syntacoll's mission is to provide innovative medical and pharmaceutical products for patient care, and their vision is to be recognized as one of the leading providers of medical and pharmaceutical products worldwide. The company values integrity, inclusion, collaboration, and responsibility. | Algemeen Directeur | 01-03-2007 | - |
Loopbaan van Alexandra Dietrich
Opleiding van Alexandra Dietrich
Ludwig-Maximilians-Universität München | Doctorate Degree |
Statistieken
Internationaal
Duitsland | 3 |
Operationeel
Doctorate Degree | 1 |
Chief Executive Officer | 1 |
Sectoraal
Consumer Services | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Syntacoll Gmbh
![]() Syntacoll Gmbh Pharmaceuticals: MajorHealth Technology Part of Innocoll Holdings Plc, Syntacoll GmbH is a German pharmaceutical company that develops and manufactures fully resorbable collagen-based implants. The company is based in Saal an der Donau, Germany and was founded in 1992. The CEOs are Alexandra Dietrich and Kimball Hall. Syntacoll is the only development and production site of Innocoll, and their products are manufactured according to GMP and ISO 13485 standards. The company holds a manufacturing license for active substance-containing drugs based on collagen. Syntacoll's mission is to provide innovative medical and pharmaceutical products for patient care, and their vision is to be recognized as one of the leading providers of medical and pharmaceutical products worldwide. The company values integrity, inclusion, collaboration, and responsibility. | Health Technology |
- Beurs
- Insiders
- Alexandra Dietrich
- Ervaring